BioSpace News Archive

Business

Select Medical and Lutheran Health Network Partner to Provide Inpatient Rehabilitation and Critical Illness Recovery Post-Acute Care to the Greater Fort Wayne Area

Select Medical Corporation and Lutheran Health Network of Indiana, LLC, a subsidiary of Community Health Systems announced the formation of a joint venture to provide inpatient rehabilitation and critical illness recovery care in Fort Wayne, Indiana.

March 13, 2023
·
3 min read
Business

Bryn Pharma Announces Appointment of Sandy Loreaux as CEO

Bryn Pharma LLC, a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, announced today that pharmaceutical industry veteran Sandy Loreaux has been appointed CEO, effective immediately.

March 13, 2023
·
3 min read
Business

Viracta Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update

Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced financial results for the fourth quarter and full year 2022 and provided an update on recent corporate developments.

March 13, 2023
·
13 min read
Business

AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023

AngioDynamics, Inc. (NASDAQ: ANGO) today announced that it will report financial results for the third quarter of fiscal year 2023 before the market open on Thursday, March 30, 2023.

March 13, 2023
·
1 min read
Business

CRISPR Therapeutics Announces Transition of Chief Financial Officer - March 13, 2023

CRISPR Therapeutics, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announces the hiring and appointment of Raju Prasad, Ph.D., as Chief Financial Officer, effective March 14, 2023.

March 13, 2023
·
5 min read
Pharm Country

Zynerba Pharmaceuticals Confirms Not Holding Cash Deposits or Securities at Silicon Valley Bank

Zynerba Pharmaceuticals, Inc., the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, issued a statement confirming that it does not hold cash deposits or securities at Silicon Valley Bank.

March 13, 2023
·
3 min read
Drug Development

Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis

Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in participants with plantar fibromatosis.

March 13, 2023
·
6 min read
Biotech Bay

Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit

Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will provide a corporate overview at the 2023 Guggenheim Healthy Altitudes Summit on Thursday, March 16, 2023 at 10:00 a.m. ET / 8:00 a.m. MT / 7:00 a.m. PT.

March 13, 2023
·
1 min read
Business

Amedisys Board Appoints Richard Ashworth as New President and Chief Executive Officer

Amedisys, Inc., the leading provider of quality home health, hospice, and high-acuity care services, announced that its Board of Directors has named Richard Ashworth as President, Chief Executive Officer, and member of the Board of Directors.

March 13, 2023
·
6 min read
BioMidwest

ZyVersa Therapeutics Reports New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 13, 2023

ZyVersa Therapeutics, Inc., a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for treatment of renal and inflammatory diseases with high unmet medical needs, announced the grant of inducement equity awards to two new employees.

March 13, 2023
·
4 min read